-
Biologics: Targets and Therapy
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Botulinum toxin type A in the treatment of patients with cervical dystonia
Review
(3054) Views (888) Full article downloads
Authors: Allison Brashear
Published Date December 2008
Volume 2009:3 Pages 1 - 7
DOI: http://dx.doi.org/10.2147/BTT.S3113
Allison Brashear
Dept of Neurology, Wake Forest University Baptist, Medical Center, Winston Salem, NC, USA
Abstract: Dystonia is an involuntary movement involving twisting and turning of agonist and antagonist muscles. Cervical dystonia is isolated to neck musculature. Botulinum toxin type A is a safe and effective treatment of this disabling and often painful syndrome. Three forms of botulinum toxin type A are available worldwide to treat patients with cervical dystonia. This is a review of the studies of botulinum toxin type A to treat cervical dystonia.
Keywords: dystonia, botulinum toxin type A, cervical dystonia
Readers of this article also read:
Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency
B cell reductive therapy with rituximab in the treatment of rheumatoid arthritis
Lutropin alpha, recombinant human luteinizing hormone, for the stimulation of follicular development in profoundly LH-deficient hypogonadotropic hypogonadal women: a review
A systematic review of new advances in the management of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): focus on galsulfase
Update on the treatment of gastrointestinal stromal tumors (GISTs): role of imatinib
Potential role of ustekinumab in the treatment of chronic plaque psoriasis
Managing idiopathic short stature: role of somatropin (rDNA origin) for injection
New and emerging treatment approaches to lupus
Eribulin mesylate in the treatment of metastatic breast cancer
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- Journal Indexing
See where all the Dove Press journals are indexed
- The benefits and risks of testosterone replacement therapy: a review
- Tenofovir-associated bone density loss
- Drug design with Cdc7 kinase: a potential novel cancer therapy target
- Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses




